Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.
2.

Glycogen-rich clear cell carcinoma of the breast.

Markopoulos C, Mantas D, Philipidis T, Kouskos E, Antonopoulou Z, Hatzinikolaou M, Gogas H.

World J Surg Oncol. 2008 Apr 29;6:44. doi: 10.1186/1477-7819-6-44.

3.

[Glycogen-rich clear-cell breast carcinoma with neuroendocrine differentiation features].

Di Tommaso L, Pasquinelli G, Portincasa G, Santini D.

Pathologica. 2001 Dec;93(6):676-80. Italian.

PMID:
11785121
4.

Trichoblastoma and basal cell carcinoma are neoplasms with follicular differentiation sharing the same profile of cytokeratin intermediate filaments.

Schirren CG, Rütten A, Kaudewitz P, Diaz C, McClain S, Burgdorf WH.

Am J Dermatopathol. 1997 Aug;19(4):341-50.

PMID:
9261468
5.

The cytokeratin profile of medullary carcinoma of the breast.

Tot T.

Histopathology. 2000 Aug;37(2):175-81.

PMID:
10931242
6.

Clear cell carcinoma of the breast with immunohistochemical evidence of divergent differentiation.

Shirley SE, Escoffery CT, Titus IP, Williams EE, West AB.

Ann Diagn Pathol. 2002 Aug;6(4):250-6.

PMID:
12170458
7.

Glycogen-rich clear cell carcinoma of the breast. A clinicopathologic study of 21 cases.

Hayes MM, Seidman JD, Ashton MA.

Am J Surg Pathol. 1995 Aug;19(8):904-11.

PMID:
7611537
8.

Cytology of glycogen-rich (clear cell) carcinoma of the breast. A report of two cases.

Kern SB, Andera L.

Acta Cytol. 1997 Mar-Apr;41(2):556-60.

PMID:
9100798
11.

Clear cell adenocarcinoma of the uterine cervix in a young pregnant woman: a case report with immunohistochemical study.

Terada T.

Med Oncol. 2011 Mar;28(1):290-3. doi: 10.1007/s12032-009-9410-x. Epub 2010 Jan 7.

PMID:
20054717
12.
13.

Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors.

Skinnider BF, Folpe AL, Hennigar RA, Lim SD, Cohen C, Tamboli P, Young A, de Peralta-Venturina M, Amin MB.

Am J Surg Pathol. 2005 Jun;29(6):747-54.

PMID:
15897741
14.

An autopsy case of clear cell adenocarcinoma of the urinary bladder.

Terada T.

Appl Immunohistochem Mol Morphol. 2013 Jul;21(4):371-5. doi: 10.1097/PAI.0b013e31821b193b.

PMID:
22024991
15.

Immunohistochemical staining characteristics of low-grade adenosquamous carcinoma of the breast.

Kawaguchi K, Shin SJ.

Am J Surg Pathol. 2012 Jul;36(7):1009-20. doi: 10.1097/PAS.0b013e31824e0f90.

PMID:
22446941
16.

Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.

Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.

Am J Surg Pathol. 2008 Apr;32(4):544-52. doi: 10.1097/PAS.0b013e31815a87e2.

PMID:
18300793
17.

An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.

Dunne B, Lee AH, Pinder SE, Bell JA, Ellis IO.

Hum Pathol. 2003 Oct;34(10):1009-15.

PMID:
14608534
18.

Cell blocks allow reliable evaluation of expression of basal (CK5/6) and luminal (CK8/18) cytokeratins and smooth muscle actin (SMA) in breast carcinoma.

Delgallo WD, Rodrigues JR, Bueno SP, Viero RM, Soares CT.

Cytopathology. 2010 Aug;21(4):259-66. doi: 10.1111/j.1365-2303.2009.00713.x. Epub 2009 Oct 15.

PMID:
19843143
19.

Centrally necrotizing carcinoma of the breast: clinicopathological analysis of 33 cases indicating its basal-like phenotype and poor prognosis.

Yu L, Yang W, Cai X, Shi D, Fan Y, Lu H.

Histopathology. 2010 Aug;57(2):193-201. doi: 10.1111/j.1365-2559.2010.03601.x.

PMID:
20716161

Supplemental Content

Support Center